Neurofibromatosis type 2

Neurofibromatosis type 2 (NF2) is a tumor-prone disorder characterized by the development of multiple schwannomas and meningiomas.



Input patient's signs and symptoms


Narrow down the case reports



Total: 201 (papers)

  


(per page)
Matched Phenotype  Gene  Mutation  MeSH
Rank
(Similarity)
PMID
(PMCID)
1
(60.5%)
22436304
(3359208)
Microdeletion del(22)(q12.2) encompassing the facial development-associated gene, MN1 (meningioma 1) in a child with Pierre-Robin sequence (including cleft palate) and neurofibromatosis 2 (NF2): a case report and review of the literature.
Davidson TB, Sanchez-Lara PA, Randolph LM, Krieger MD, Wu SQ, Panigrahy A, Shimada H, Erdreich-Epstein A.
BMC Med Genet. 2012;13:19.
Glossoptosis Micrognathia
MN1 NF2 PITPNB TTC28
rs147334255
Adult Animals Base Pairing Child Child, Preschool Chromosome Deletion Chromosomes, Human, Pair 22 Cleft Palate Facies Females Homo sapiens Infant Infant, Newborn Maxillofacial Development Mus Neurofibromatosis 2 Pierre Robin Syndrome Pregnancy Trans-Activators Tumor Suppressor Proteins
2
(49.0%)
23453897
Macrodactyly in the setting of a plexiform schwannoma in neurofibromatosis type 2: case report.
Bendon CL, Giele HP.
J Hand Surg Am. 2013;38(4):740-4.
Macrodactyly Small finger
Child Fingers Health Risk Assessment Homo sapiens Limb Deformities, Congenital Male Neurofibromatosis 2 Plexiform Neurofibroma Rare Diseases
3
(40.9%)
29147294
(5649792)
Meningioangiomatosis Without Neurofibromatosis Type 2.
Marzi S, De Paulis D, Ricci A, Taddei G, Dehcordi SR, Coletti G, Maselli G, Galzio RJ.
World J Oncol. 2012;3(3):127-133.
Sinusitis
4
(38.2%)
19629903
Infantile onset neurofibromatosis type 2 presenting with peripheral facial palsy, skin patches, retinal hamartoma and foot drop.
Tibussek D, Hubsch S, Berger K, Schaper J, Rosenbaum T, Mayatepek E.
Klin Padiatr. 2009;221(4):247-50.
Retinal hamartoma Facial palsy
NF2
Cafe-au-Lait Spots Child Child, Preschool Chromosome Aberrations Cranial Nerve Neoplasms Differential Diagnosis Fluorescein Angiography Follow-Up Studies Genes, Dominant Hamartoma Homo sapiens Infant Infant, Newborn Leg Magnetic Resonance Imaging Male Muscle Weakness Neurilemmoma Neurofibromatosis 2 Neuromuscular Diseases Retinal Diseases Vestibulocochlear Nerve Diseases
5
(35.3%)
22710553
Management of hearing in pediatric NF2.
Shepard TH, Tucci DL, Grant GA, Kaylie DM.
Otol Neurotol. 2012;33(6):1066-70.
Facial paralysis
NF2
Angiogenesis Inhibitors Antibodies, Monoclonal, Humanized Auditory Brain Stem Implants Child Combined Modality Therapy Females Homo sapiens Intraoperative Complications Labyrinth Magnetic Resonance Imaging Male Neurilemmoma Neurofibromatosis 2
5
(35.3%)
21968382
Facial reanimation of patients with neurofibromatosis type 2.
Vakharia KT, Henstrom D, Plotkin SR, Cheney M, Hadlock TA.
Neurosurgery. 2012;70(2 Suppl Operative):237-43.
Facial paralysis
NF2 TMTC3
Adult Child Females Homo sapiens Male Middle Aged Neurofibromatosis 2 Retrospective Studies Tissue Transplantation Young Adult
5
(35.3%)
17159493
Intracochlear hemorrhage after gamma knife radiosurgery.
Franco-Vidal V, Songu M, Blanchet H, Barreau X, Darrouzet V.
Otol Neurotol. 2007;28(2):240-4.
Facial paralysis
NF2
Adult Audiometry, Pure-Tone Cochlear Diseases Deafness Hemorrhage Homo sapiens Magnetic Resonance Imaging Male Neurofibromatosis 2 Radiosurgery
8
(29.2%)
29534265
[Retinal Astrocytic Hamartoma in Neurofibromatosis Type 2 - Metaanalysis and a Case Report].
Starosta DA, Lorenz B.
Klin Monbl Augenheilkd. 2018;235(3):290-300.
Cataract Retinal hamartoma
NF2 PLXNA2
Astrocytes DNA Mutational Analysis Diagnostic Techniques, Ophthalmological Differential Diagnosis Females Fluorescein Angiography Hamartoma Homo sapiens Meningeal Neoplasms Meningioma Neurofibromatosis 2 Neurofibromin 2 Retinal Diseases Tomography, Optical Coherence
8
(29.2%)
26047750
[Early type 2 neurofibromatosis and congenital retinal hamartoma].
Herisse AL, Poiree M, Boyer C, Soler C, Leloutre B, Geoffray A.
Arch Pediatr. 2015;22(7):729-32.
Amblyopia Retinal hamartoma
NF2
Child Females Hamartoma Homo sapiens Neurofibromatosis 2 Retinal Diseases
8
(29.2%)
25439059
[Type 2 neurofibromatosis: intergenerational differences in genetic and clinical expression].
Drouet A, Le Moigne F, Salame D, Quesnel L, Motolese C, des Portes V, Guilloton L, Pinson S.
Arch Pediatr. 2014;21(11):1233-40.
Retinal hamartoma
COX8A NF2
Adult Child Chromosome Deletion Early Diagnosis Exons Gene Expression Genes, Dominant Homo sapiens Male Mosaicism Neurofibromatosis 2 Neurofibromin 2 Phenotype
        

Phenotype(s) retrieved from Orphanet

    Total: 25

HPO ID Term Frequency
HP:0000360 Tinnitus Very frequent (99-80%)
HP:0000407 Sensorineural hearing impairment Very frequent (99-80%)
HP:0001251 Ataxia Very frequent (99-80%)
HP:0002321 Vertigo Very frequent (99-80%)
HP:0000518 Cataract Frequent (79-30%)
HP:0002076 Migraine Frequent (79-30%)
HP:0008069 Neoplasm of the skin Frequent (79-30%)
HP:0000505 Visual impairment Occasional (29-5%)
HP:0000763 Sensory neuropathy Occasional (29-5%)
HP:0001288 Gait disturbance Occasional (29-5%)
HP:0001482 Subcutaneous nodule Occasional (29-5%)
HP:0002516 Increased intracranial pressure Occasional (29-5%)
HP:0002858 Meningioma Occasional (29-5%)
HP:0006824 Cranial nerve paralysis Occasional (29-5%)
HP:0007565 Multiple cafe-au-lait spots Occasional (29-5%)
HP:0007957 Corneal opacity Occasional (29-5%)
HP:0008046 Abnormal retinal vascular morphology Occasional (29-5%)
HP:0009193 Pseudoepiphyses of the metacarpals Occasional (29-5%)
HP:0009592 Astrocytoma Occasional (29-5%)
HP:0009595 Occasional neurofibromas Occasional (29-5%)
HP:0010526 Dysgraphia Occasional (29-5%)
HP:0010628 Facial palsy Occasional (29-5%)
HP:0100006 Neoplasm of the central nervous system Occasional (29-5%)
HP:0100835 Benign neoplasm of the central nervous system Occasional (29-5%)
HP:0200034 Papule Occasional (29-5%)


Phenotype(s) retrieved from case reports

    Total: 47

HPO ID Term # of case reports
HP:0100008 Schwannoma 28
HP:0002888 Ependymoma 7
HP:0001067 Neurofibromas 6
HP:0001250 Seizures 4
HP:0002664 Neoplasm 3
HP:0000520 Proptosis 2
HP:0000969 Edema 2
HP:0001297 Stroke 2
HP:0100014 Epiretinal membrane 2
HP:0000360 Tinnitus 1
HP:0000508 Ptosis 1
HP:0000518 Cataract 1
HP:0000651 Diplopia 1
HP:0001085 Papilledema 1
HP:0001118 Juvenile cataract 1
HP:0001138 Optic neuropathy 1
HP:0001249 Intellectual disability 1
HP:0001271 Polyneuropathy 1
HP:0001287 Meningitis 1
HP:0001618 Dysphonia 1
HP:0001742 Nasal obstruction 1
HP:0002133 Status epilepticus 1
HP:0002176 Spinal cord compression 1
HP:0002315 Headache 1
HP:0002321 Vertigo 1
HP:0002835 Aspiration 1
HP:0002861 Melanoma 1
HP:0002870 Obstructive sleep apnea 1
HP:0004099 Macrodactyly 1
HP:0007263 Spinocerebellar atrophy 1
HP:0007352 Cerebellar calcifications 1
HP:0008443 Spinal deformities 1
HP:0008554 Cochlear malformation 1
HP:0009594 Retinal hamartoma 1
HP:0009737 Lisch nodules 1
HP:0009792 Teratoma 1
HP:0009830 Peripheral neuropathy 1
HP:0009831 Mononeuropathy 1
HP:0010566 Hamartoma 1
HP:0012733 Macule 1
HP:0030033 Small finger 1
HP:0030430 Neuroma 1
HP:0030838 Hip pain 1
HP:0031501 Pelvic mass 1
HP:0100242 Sarcoma 1
HP:0100698 Subcutaneous neurofibromas 1
HP:0100790 Hernia 1


Causative gene(s) retrieved from Orphanet

    Total: 1

Gene Symbol Gene Name Entrez Gene ID
NF2 neurofibromin 2 4771